ATI RN
Immune System Disorders Quizlet Questions
Question 1 of 5
The nurse realizes that the patient understands the teaching about decreasing the risk for antibiotic-resistant infection when the patient says which of the following?
Correct Answer: D
Rationale: The correct answer is D) "I will follow the directions for taking the antibiotic so I will get over this infection." This response indicates understanding of the importance of completing the full course of antibiotics as prescribed. This is crucial to ensure the infection is completely eradicated, reducing the risk of antibiotic resistance. Option A is incorrect because stopping antibiotics early can lead to incomplete treatment and potential antibiotic resistance. Option B is incorrect as antibiotics are not effective against viral infections like the common cold. Option C is also incorrect as saving antibiotics for future use can lead to inappropriate self-medication and the development of resistance. In an educational context, it is vital to emphasize the proper use of antibiotics to prevent resistance. Educating patients on the importance of adherence to prescribed regimens helps maintain the effectiveness of antibiotics for future infections. Understanding these concepts empowers patients to be active participants in their healthcare and promotes responsible antibiotic use.
Question 2 of 5
A patient is admitted with acute myelogenous leukemia and a history of Hodgkin’s lymphoma. What is the nurse likely to find in the patient’s history?
Correct Answer: D
Rationale: In this scenario, the correct answer is D) Alkylating agents for treating the Hodgkin’s lymphoma. This is because alkylating agents are a class of chemotherapy drugs commonly used in the treatment of Hodgkin’s lymphoma, which is a type of cancer affecting the lymphatic system. Patients with a history of Hodgkin’s lymphoma are often treated with alkylating agents like mechlorethamine, cyclophosphamide, or procarbazine. Option A) Work as a radiation chemist is incorrect because it is not directly related to the patient’s medical history of leukemia and Hodgkin’s lymphoma. Option B) Epstein-Barr virus diagnosed in vitro is also incorrect as it is not typically associated with the treatment or history of these specific types of cancers. Option C) Intense tanning throughout the lifetime is not relevant to the patient’s medical history and does not provide any information related to their diagnosis or treatment. In an educational context, understanding the patient’s medical history is crucial for providing safe and effective care, especially in pharmacology. Knowing the patient’s previous treatments, medications, and diagnoses can help healthcare providers make informed decisions regarding current and future treatments, as certain drugs may interact with previous therapies or conditions. This question highlights the importance of pharmacological knowledge in the context of cancer treatment and the impact of past treatments on current health conditions.
Question 3 of 5
Which patient would be most likely to be cured with chemotherapy as a treatment measure?
Correct Answer: B
Rationale: In the context of pharmacology and immune system disorders, understanding the appropriate use of chemotherapy is crucial. In this quiz question, the correct answer is B) New neuroblastoma. Neuroblastoma is a type of cancer that originates in nerve tissue and is commonly found in young children. Chemotherapy is often an effective treatment for neuroblastoma due to its ability to target rapidly dividing cells, which is a hallmark of cancer cells. In the case of a new neuroblastoma, where the cancer is at an early stage and has not spread extensively, chemotherapy stands a good chance of curing the patient by eradicating the cancerous cells. Now, let's analyze why the other options are incorrect: A) Small cell lung cancer: While chemotherapy is a common treatment for small cell lung cancer, the word "cured" is rarely associated with this treatment due to the aggressive nature of the disease and the likelihood of recurrence. C) Small tumor of the bone: Chemotherapy is not typically the first-line treatment for small tumors of the bone. Surgical removal or localized treatments like radiation therapy are usually preferred. D) Large hepatocellular carcinoma: Chemotherapy may be used to slow the progression of hepatocellular carcinoma or to shrink the tumor before surgery, but curing this advanced stage cancer with chemotherapy alone is unlikely. Understanding the appropriate use of chemotherapy in different types and stages of cancer is essential for healthcare professionals involved in the treatment of patients with immune system disorders. This knowledge helps in making informed decisions regarding the most effective treatment strategies based on individual patient conditions, ultimately aiming for the best possible outcomes.
Question 4 of 5
When the patient asks about the late effects of chemotherapy and high-dose radiation, what areas of teaching should the nurse plan to include when describing these effects?
Correct Answer: B
Rationale: The correct answer is B) Secondary malignancies. When a patient asks about the late effects of chemotherapy and high-dose radiation, it is crucial for the nurse to address the risk of developing secondary malignancies. This is because exposure to high doses of radiation and certain chemotherapeutic agents can damage healthy cells, increasing the risk of developing new cancers later in life. Option A) Third space syndrome is incorrect in this context as it typically refers to the shift of fluid from the intravascular space to the interstitial space, causing edema and hypovolemia. While this can be a complication of certain conditions or treatments, it is not directly related to the late effects of chemotherapy and radiation. Option C) Chronic nausea and vomiting are common side effects of chemotherapy but are not typically considered late effects. These symptoms usually improve once the treatment is completed, and addressing them does not encompass the full scope of potential late effects. Option D) Persistent myelosuppression is a valid concern with chemotherapy and radiation, but it primarily refers to prolonged suppression of bone marrow function leading to decreased blood cell production. While this can have long-term consequences, the development of secondary malignancies is a more significant late effect that patients should be aware of. In an educational context, it is important for nurses to provide comprehensive information to patients about the potential long-term effects of cancer treatments. By understanding and discussing these late effects, patients can make informed decisions about their care and be proactive in monitoring for any signs of complications post-treatment.
Question 5 of 5
What is the primary goal of palliative care in cancer treatment?
Correct Answer: C
Rationale: In the context of cancer treatment, the primary goal of palliative care is to relieve suffering and improve the quality of life for patients. This is why option C, "Relieve suffering and improve quality of life," is the correct answer. Option A, "Cure the disease," is not the primary goal of palliative care. Palliative care focuses on providing relief from the symptoms and stress of a serious illness like cancer, rather than aiming for a cure. Option B, "Extend life expectancy," while important in some treatment contexts, is not the primary goal of palliative care. It is more aligned with curative or life-prolonging treatments. Option D, "Prevent disease recurrence," is also not the primary goal of palliative care. Preventing disease recurrence is typically addressed through specific cancer treatments such as surgery, chemotherapy, or radiation therapy, rather than through palliative care. In an educational context, it is crucial for students in pharmacology to understand the goals and principles of palliative care in cancer treatment. This knowledge helps healthcare professionals provide holistic and patient-centered care to individuals with cancer, focusing not only on medical interventions but also on improving their quality of life and managing symptoms effectively. Understanding the role of palliative care is essential for comprehensive patient care and ensuring that patients receive the support they need throughout their cancer journey.